Since Ang II-induced mitochondrial metabolic shift is considered a cause of cardiac hypertrophy, Ang II infusion has been shown to reduce cardiac fatty acid oxidation associated with enhanced glycolysis. This evidence concerns the gene AGT and cardiac hypertrophy.